In replay of a courtroom battle that ended in a mistrial last year, a federal jury voted unanimously that Merck’s Fosamax osteoporosis drug was responsible for causing jawbone deterioration suffered by a Florida woman, who was awarded $8 million in compensatory damages (here is the lawsuit).
Read article at pharmalot.com
Monday, July 05, 2010
Merck To Pay $8M Damages re Fosamax bone deterioration
Subscribe to:
var sc_project=1725605;
var sc_invisible=0;
var sc_partition=16;
var sc_security="acf71b9a";